Noninvasive assessment of neuromuscular disease using electrical impedance (Skulpt Inc. EIM)

ALS Subjects:

• Male or female, aged 35 to 80
• Recent diagnosis of sporadic or familial ALS
• Symptom onset less than 24 months before screening visit
• Geographically accessible to the University of Miami Miller School of Medicine

Healthy Control subjects:

• Male or female, aged 35 to 80
• Absence of a known neurological disorder
• Geographically accessible to the University of Miami Miller School of Medicine

Neuromuscular disorder subjects:

• Male or female, aged 35 to 80.
• Diagnosis of one of the following:
  • Multi-focal motor neuropathy
  • Autoimmune motor neuropathy
  • Pinched nerve in the neck or back causing weakness in the arms or legs
  • Weakness caused by neuropathy
  • Charcot-Marie-Tooth Disease
  • Cervical myelopathy
  • Multiple sclerosis
  • Hereditary spastic paraplegia
• Geographically accessible to the University of Miami Miller School of Medicine

Skulpt Inc. via funding from

National Institutes of Health

• Massachusetts General Hospital
• State University of New York Upstate Medical University
• Wake Forest University Baptist Medical Center
• Skulpt, Inc.

Research Coordinator

• Sumaira Hussain, B.Sc.

Contact Information

• Email: sumaira.hussain@med.miami.edu
• Phone: 305-243-8487

• Skulpt Health

• Bohorquez J, Jutkove S, Benatar M, Caress J, David W, Ensrud E, Shefner J. Electrical impedance myography for early diagnosis and assessment of ALS progression: Results of a multicenter clinical trial.  Platform presentation at the 27^th International Symposium on ALS/MND, Dublin, Ireland, Dec 7-9, 2016.